Table 2 Generalized linear model between dyslipidemia status and change in telomere length
From: Persistent dyslipidemia increases the longitudinal changes in telomere length
Healthy persistently | Dyslipidemia in baseline or follow-up | Dyslipidemia persistently | ||||
|---|---|---|---|---|---|---|
B (95%CI) | P-value | B (95%CI) | P-value | B (95%CI) | P-value | |
Total | 1 (Reference) | 0.361(0.05–0.67) | 0.023 | 0.630(0.17–1.09) | < 0.001 | |
Male | 1 (Reference) | 0.667(0.12–1.21) | 0.017 | 0.710(-0.08-1.50) | 0.077 | |
Female | 1 (Reference) | 0.166(-0.20-0.53) | 0.376 | 0.570(0.02–1.12) | 0.044 | |
< 60 | 1 (Reference) | 0.206(-0.19-0.60) | 0.303 | 0.402(-0.19-1.00) | 0.184 | |
≥ 60 | 1 (Reference) | 0.600(0.09–1.11) | 0.020 | 0.951(0.23–1.68) | 0.010 | |